Literature DB >> 28000544

The Complex Inter-Relationship Between Diabetes and Schizophrenia.

Robert P Hoffman1.   

Abstract

Schizophrenia is a chronic and debilitating brain disorder. It is associated with increased mortality, primarily due to elevated cardio-metabolic risk. Affected patients have higher rates of obesity, metabolic syndrome and diabetes [1]. Intrinsic factors contributing to this increased risk include a shared underlying pathophysiology between schizophrenia and diabetes mellitus involving stress, inflammation and genetics. Extrinsic contributing factors include diet, lifestyle, health care access, low socioeconomic status and overburden of traditional diabetes risk factors. Antipsychotics are associated with an increased risk of obesity, metabolic syndrome and diabetes mellitus [1]. Appetite-regulating hormones, pharmacodynamics and alterations in glucose metabolism may underlie the negative effect of these medications. Reduction in diabetes risk is achieved by mitigating traditional risk factors. Non-pharmacologic and pharmacologic approaches to cardio-metabolic risk reduction may be helpful in these patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Antipsychotics; diabetes mellitus; metabolic syndrome; obesity; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28000544     DOI: 10.2174/1573399812666161201205322

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  10 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

Review 2.  Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective.

Authors:  Jillian S Weissenrieder; Jeffrey D Neighbors; Richard B Mailman; Raymond J Hohl
Journal:  J Pharmacol Exp Ther       Date:  2019-04-18       Impact factor: 4.030

3.  Use of skin advanced glycation end product levels measured using a simple noninvasive method as a biological marker for the diagnosis of neuropsychiatric diseases.

Authors:  Hiroki Yamashita; Eriko Fukushima; Kaori Shimomura; Hitoki Hirose; Ken Nakayama; Narihiro Orimo; Wanyi Mao; Narimasa Katsuta; Shohei Nishimon; Tohru Ohnuma
Journal:  Int J Methods Psychiatr Res       Date:  2020-04-23       Impact factor: 4.035

4.  Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia.

Authors:  Anastasiia S Boiko; Irina A Mednova; Elena G Kornetova; Nikolay A Bokhan; Arkadiy V Semke; Anton J M Loonen; Svetlana A Ivanova
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-22       Impact factor: 2.570

5.  Relationships of complement components C3 and C4 and their genetics to cardiometabolic risk in healthy, non-Hispanic white adolescents.

Authors:  Melanie M Copenhaver; Chack-Yung Yu; Danlei Zhou; Robert P Hoffman
Journal:  Pediatr Res       Date:  2019-08-12       Impact factor: 3.756

6.  Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients.

Authors:  Inmaculada Guerrero Fernández de Alba; Antonio Gimeno-Miguel; Beatriz Poblador-Plou; Luis Andrés Gimeno-Feliu; Ignatios Ioakeim-Skoufa; Gemma Rojo-Martínez; Maria João Forjaz; Alexandra Prados-Torres
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

7.  Quality of diabetes care in patients with schizophrenia: a case-control study in Qatar.

Authors:  Mustafa Abdul Karim; Nadeen Al-Baz; Sami Ouanes; Ali Khalil; Ahmed H Assar; Abdulkarim Alsiddiqi; Zeinab Dabbous; Mahmoud Zirie; Peter Woodruff; Rayaz A Malik; Peter M Haddad
Journal:  BMC Psychiatry       Date:  2021-03-12       Impact factor: 3.630

8.  Prospective cohort study of the evaluation of patient benefit from the redevelopment of a complete national forensic mental health service: the Dundrum Forensic Redevelopment Evaluation Study (D-FOREST) protocol.

Authors:  Mary Davoren; Ken O'Reilly; Damian Mohan; Harry G Kennedy
Journal:  BMJ Open       Date:  2022-07-22       Impact factor: 3.006

9.  Prevalence and clinical characteristics of COVID-19 in inpatients with schizophrenia in Wuhan, China.

Authors:  Hong-Wei Sheng; Hong-Gang Wang; Chun-Zhi Wang; Jiang Wu; Li-Jian Huo; Ruo-Xi Wang; Yong-Jie Zhou; Xiang-Yang Zhang
Journal:  World J Psychiatry       Date:  2022-01-19

10.  Retinal Microvasculature in Schizophrenia.

Authors:  Steven M Silverstein; Adriann Lai; Kyle M Green; Christen Crosta; Samantha I Fradkin; Rajeev S Ramchandran
Journal:  Eye Brain       Date:  2021-07-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.